HOME
RESEARCH & DEVELOPMENT
TEAM
CODE OF CONDUCT
TECHNOLOGY
PRODUCTS
HUMAN HEALTH
FOOD SAFETY
AGRICULTURE
ANIMAL HEALTH
PUBLICATIONS
NEWS
INVESTOR RELATIONS
CAREERS
CONTACT
MICREOS FOOD SAFETY
MICREOS HUMAN HEALTH
Sitemap
Technology
Home
Research and Development
Team
Code of Conduct
Products
Human Health
Food Safety
Agriculture
Animal Health
NEWS
Careers
Publications
Investor Relations
Contact
Sitemap side content
NEWS
Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance
Staphylococcus aureus cells undergoing lysis by the action of XZ.700 PRESS RELEASE ...
Micreos Pharmaceuticals welcomes Trine Ahlgreen and Carsten Edwards to its Executive team to accelerate its next phase of development
PRESS RELEASE Zug, Switzerland, 5-April 2022 — Micreos Pharmaceuticals today a ...
Micreos appoints Joost Goderie as CFO and member of the Board of Directors
PRESS RELEASE The Hague, The Netherlands, January 28, 2022 - Micreos announced that it has ap ...
New clinical study proves safe anti-S. aureus endolysin ‘Staphefekt SA.100’ significantly reduces eczema symptoms
PRESS RELEASE - FOR IMMEDIATE RELEASE The Hague, December 7, 2021.A new study, published in t ...
Micreos appoints Matt Regan as CEO of its Pharmaceutical business
PRESS RELEASE The Hague, October 14, 2021 - Dutch biotechnology company Micreos has recr ...
More news
© 2010 - MICREOS
Careers
Disclaimer
Privacy Policy
Contact
Sitemap